The Portland Podcast

Dr. Brian Druker & Devin Kelly of Oregon Active

Gregory Day

Brian Druker, M.D., revolutionized the treatment of cancer through research that resulted in the first drug to target the molecular defect of a cancer while leaving healthy cells unharmed. Marketed under the name Gleevec®, his discovery turned a once-fatal cancer, chronic myeloid leukemia, into a manageable condition.  Devin Kelly of Oregon Active & chats with us about the nonprofit. Music licensed from Soundstripe.

Support the show